Filters
reset allTests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Common Hereditary Cancer Screening Panel PreventionGenetics, part of Exact Sciences United States | 94 | 55 |
|
Centogene AG - the Rare Disease Company Germany | 114 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
SDHD - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 4 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 36 | 19 |
|
Invitae Nuclear Mitochondrial Disorders Panel Invitae United States | 394 | 319 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae United States | 409 | 164 |
|
Invitae United States | 160 | 62 |
|
Invitae 78 Gene Actionable Disorders Panel Invitae United States | 220 | 75 |
|
SDHD - hereditary paraganglioma and pheochromocytoma Translational Metabolic Laboratory Radboud University Medical Centre Netherlands | 2 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 78 | 64 |
|
Hereditary Pheochromocytoma and Paraganglioma Panel Genetic Services Laboratory University of Chicago United States | 10 | 16 |
|
PreventionGenetics, part of Exact Sciences United States | 33 | 25 |
|
Hereditary Paraganglioma-Pheochromocytoma Syndrome via the SDHD Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
Hereditary Paraganglioma-Pheochromocytoma Expanded Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 12 | 12 |
|
Hereditary endocrine cancer panel. NGS panel of 22 genes. Genologica Medica Spain | 68 | 22 |
|
Hereditary kidney cancer panel. NGS panel of 26 genes. Genologica Medica Spain | 74 | 26 |
|
Hereditary Paraganglioma-Pheochromocytoma Genologica Medica Spain | 32 | 12 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.